MedTrace Logo

Co-design of a Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 Using Voice

NCT05546918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2024-02-09

No results posted yet for this study

Summary

The UpcomingVoice project aims to co-design a digital health solution based on vocal biomarkers for screening and self-monitoring of frequently reported COVID-19-related symptoms with its end-users: 1) people with persisting COVID-19 related symptoms, with or without a Long COVID diagnosis and 2) healthcare professionals involved in the care of Long COVID patients.

To achieve this objective the UpcomingVoice study will determine:

* The needs, expectancies, acceptability, fears, barriers and leverages of the end-users regarding the use of voice to self-monitor or screen for Long COVID symptoms
* The specifications that such a mobile application should meet in order to be considered acceptable and effective by its intended users in terms of technological aspects (type of device, type of voice recordings…), frequency of utilisation, design etc.

The project consists in 2 separate parts : one anonymous online survey and one qualitative part based on semi-structured interviews and focus groups.

The results of this study will be the specifications of a voice-based digital health solution.

Conditions

Interventions

OTHER

survey, interviews and focus groups

The 2 groups of participants will be invited to: * complete an anonymous online survey * participate in individual semi-structured interviews and 2 focus groups

Sponsors & Collaborators

  • Luxembourg Institute of Health

    lead OTHER_GOV

Principal Investigators

  • Aurelie FISCHER, MSc · Luxembourg Institute of Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-02-08
Completion
2024-02-08

Countries

  • Luxembourg

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05546918 on ClinicalTrials.gov